Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Multitarget Drug Design for Cardiovascular Disease: Bridging Chemistry and Medicine.

Created on 14 Oct 2026

Authors

Gyuzel Y Mitronova, Vladimir N Belov, Constanze Schmidt, Stephan E Lehnart

Published in

ChemMedChem. Volume 21. Issue 19. Pages e70506. Oct 14, 2026.

Abstract

This review provides an overview of recent advances in the development of multitarget drugs (MTDs) for cardiac diseases, with a particular focus on emerging molecular scaffolds and their pharmacological properties. We discuss the fundamental principles of cardiac polypharmacology and multitarget drug design, highlighting key compound classes, such as 1,4-benzothiazepines, 1,4-dihydropyridines (DHPs), and polyphenol derivatives. Particular emphasis is placed on the relationship between the structural features and the pharmacological activity, efficacy, and therapeutic potential of these compounds.

PMID:
42870355
Bibliographic data and abstract were imported from PubMed on 14 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement